Currently out of the existing stock ratings of Edward White, 505 are a BUY (96.01%), 19 are a HOLD (3.61%), 2 are a SELL (0.38%).

Edward White

Work Performance Price Targets & Ratings Chart

Analyst Edward White, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 27.81% that have a potential upside of 38.46% achieved within 148 days.

Edward White’s has documented 984 price targets and ratings displayed on 49 stocks. The coverage is on Healthcare, Industrials, Consumer Cyclical, Financial Services, Communication Services sectors.

Most recent stock forecast was given on CGEM, Cullinan Oncology LLC at 16-Apr-2025.

Wall Street Analyst Edward White

Analyst best performing recommendations are on SBTX (SILVERBACK THERAPEUTICS ).
The best stock recommendation documented was for MRTX (MIRATI THER) at 11/15/2017. The price target of $17 was fulfilled within 1 day with a profit of $2.95 (21%) receiving and performance score of 209.96.

Average potential price target upside

LUMO Lumos Pharma CLVS Clovis Oncology CMRX Chimerix DVAX Dynavax Technologies GTHX G1 Therapeutics IFRX InflaRx N.V. INZY Inozyme Pharma  TGTX TG Therapeutics VALN Valneva SE ADR VYNT Vyant Bio XLRN Acceleron Pharma CORI Corium International KPTI Karyopharm Therapeutics PBYI Puma Biotechnology SNDX Syndax Pharmaceuticals SPPI Spectrum Pharmaceuticals ACET Adicet Bio AGLE Aeglea Bio Therapeutics CGEM Cullinan Oncology LLC GLYC GlycoMimetics SABS SAB Biotherapeutics BOLT Bolt Biotherapeutics CRIS Curis IKT Inhibikase Therapeutics  NYXH Nyxoah ALNA Allena Pharmaceuticals CCXI ChemoCentryx SBTX Silverback Therapeutics  IDYA Ideaya Biosciences LJPC La Jolla Pharmaceutical Co MRSN Mersana Therapeutics MRTX Mirati Ther TCON TRACON Pharmaceuticals AURA Aura Biosciences FATE Fate Therapeutics LRMR Larimar Therapeutics SNSE Sensei Biotherapeutics ALRN Aileron Therapeutics AVTX Avalo Therapeutics AL Air Lease ARTV Artiva Biotherapeutics, Common Stock CM Canadian Imperial Bank Of Commerce DVA DaVita HealthCare Partners GL Globe Life GT Goodyear Tire & Rubber Co LU Lufax Holding Ltd TC TuanChe ADR AGL agilon health LGVN Longeveron LLC

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 08-Nov-2024

$4.25

$-0.09 (-2.07%)

$4.25

1 years 8 months 22 days ago
(08-Nov-2024)

2/7 (28.57%)

$-0.11 (-2.52%)

93

Buy Since 13-Apr-2021

$4.25

$-0.09 (-2.07%)

$34

1 years 9 months 7 days ago
(23-Oct-2024)

0/2 (0%)

$-0.11 (-2.52%)

Buy Since 20-Jul-2022

1 years 11 months 28 days ago
(02-Aug-2024)

0/1 (0%)

$12.65 (172.11%)

Buy Since 03-Dec-2020

$10

$5.66 (130.41%)

$10

2 years 11 months 8 days ago
(22-Aug-2023)

1/3 (33.33%)

$7.03 (236.70%)

28

Buy Since 16-Apr-2020

$7

$2.66 (61.29%)

3 years 7 months 22 days ago
(08-Dec-2022)

1/3 (33.33%)

$2.8 (66.67%)

33

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Edward White?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?